Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
175 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003206 | Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 15, 2023 | clinicaltrials |
| NCT00003235 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed | completed | Phase 3 | 294 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 |
| clinicaltrials |
| NCT00003283 | Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma | completed | Phase 2 | 38 | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 15, 2023 | clinicaltrials |
| NCT00003329 | Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | completed | — | 4,000 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00003519 | Combination Chemotherapy in Treating Women With Breast Cancer | completed | Phase 3 | 2,778 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00003614 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 15, 2023 | clinicaltrials |
| NCT00003615 | Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | 77 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00003701 | Combination Chemotherapy in Treating Patients With Bladder Cancer | completed | Phase 3 | 490 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00003810 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00003864 | Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 3 | Jun 15, 2023 | clinicaltrials |
| NCT00004125 | Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00004860 | Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 15, 2023 | clinicaltrials |
| NCT00006004 | Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 4 | Jun 15, 2023 | clinicaltrials |
| NCT00014118 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00026286 | Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00027859 | Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00028990 | Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 722 | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 15, 2023 | clinicaltrials |
| NCT00041314 | Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 4 | Jun 15, 2023 | clinicaltrials |
| NCT00049348 | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00049517 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia | completed | Phase 3 | 657 | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 15, 2023 | clinicaltrials |
| NCT00054561 | Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 5 | Jun 15, 2023 | clinicaltrials |
| NCT00060398 | Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 3 | 282 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00082797 | High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 2 | 36 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00090974 | Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer | completed | — | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT03370367 | Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer | completed | Phase 3 | 189 | Eastern Cooperative Oncology GroupNETWORK | 0 | Jun 15, 2023 | clinicaltrials |
| NCT00002826 | Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 36 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 7, 2023 | clinicaltrials |
| NCT00499291 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | withdrawn | N/A | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 25, 2023 | clinicaltrials |
| NCT00771017 | Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 25, 2023 | clinicaltrials |
| NCT02344810 | C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 1 | May 25, 2023 | clinicaltrials |
| NCT00357630 | Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary | completed | Phase 2 | 52 | Eastern Cooperative Oncology GroupNETWORK | 1 | Nov 2, 2020 | clinicaltrials |
| NCT00101140 | Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 19, 2017 | clinicaltrials |
| NCT01385150 | Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia | completed | — | 220 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 19, 2017 | clinicaltrials |
| NCT00897299 | Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy | completed | — | 900 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT00897559 | Study of Bone Marrow Samples From Patients With Acute Leukemia | completed | — | 40 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT00899080 | Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide | completed | — | 33 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01145469 | Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy | completed | — | 225 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01150643 | Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | completed | — | 559 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01388569 | Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim | completed | — | 48 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01390597 | Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms | completed | — | 32 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01406782 | DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402 | completed | — | 200 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01421875 | Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia | completed | — | 257 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01466244 | Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397 | completed | — | 42 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01487733 | Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301 | completed | — | 155 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01489423 | Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim | completed | — | 270 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01505699 | Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia | completed | — | 186 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01619618 | Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial | completed | — | 183 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01672905 | PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 | completed | — | 20 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT00093678 | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer | withdrawn | N/A | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 8, 2015 | clinicaltrials |
| NCT00227773 | Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 8, 2015 | clinicaltrials |
| NCT00469976 | Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 8, 2015 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials